Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stomatological tamponade Contipro for Alveolar Osteitis
NCT04091399Phase 2Completed
- Sponsor
- Contipro
- Start
- Sep 2015
- Primary completion
- Feb 2016
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in alveolar osteitis (AO), sponsored by Contipro. Primary endpoint: Number of patients with treatment-related adverse effects at 7 days. Started Sep 2015; status: completed.
02
Conditions
alveolar osteitis (AO)
Beyond the preview
Go deeper on NCT04091399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04091399.